Literature DB >> 10085022

Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein.

M del Poeta1, D L Toffaletti, T H Rude, S D Sparks, J Heitman, J R Perfect.   

Abstract

Synthetic green fluorescent protein (GFP) was used as a reporter to detect differential gene expression in the pathogenic fungus Cryptococcus neoformans. Promoters from the C. neoformans actin, GAL7, or mating-type alpha pheromone (MFalpha1) genes were fused to GFP, and the resulting reporter genes were used to assess gene expression in serotype A C. neoformans. Yeast cells containing an integrated pACT::GFP construct demonstrated that the actin promoter was expressed during vegetative growth on yeast extract-peptone-dextrose medium. In contrast, yeast cells containing the inducible GAL7::GFP or MFalpha1::GFP reporter genes expressed significant GFP activity only during growth on galactose medium or V-8 agar, respectively. These findings demonstrated that the GAL7 and MFalpha1 promoters from a serotype D C. neoformans strain function when introduced into a serotype A strain. Because the MFalpha1 promoter is induced by nutrient deprivation and the MATalpha locus containing the MFalpha1 gene has been linked with virulence, yeast cells containing the pMFalpha1::GFP reporter gene were analyzed for GFP expression in the central nervous system (CNS) of immunosuppressed rabbits. In fact, significant GFP expression from the MFalpha1::GFP reporter gene was detected after the first week of a CNS infection. These findings suggest that there are temporal, host-specific cues that regulate gene expression during infection and that the MFalpha1 gene is induced during the proliferative stage of a CNS infection. In conclusion, GFP can be used as an effective and sensitive reporter to monitor specific C. neoformans gene expression in vitro, and GFP reporter constructs can be used as an approach to identify a novel gene(s) or to characterize known genes whose expression is regulated during infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085022      PMCID: PMC96532          DOI: 10.1128/IAI.67.4.1812-1820.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression.

Authors:  K Okubo; N Hori; R Matoba; T Niiyama; A Fukushima; Y Kojima; K Matsubara
Journal:  Nat Genet       Date:  1992-11       Impact factor: 38.330

2.  Green fluorescent protein as a marker for gene expression.

Authors:  M Chalfie; Y Tu; G Euskirchen; W W Ward; D C Prasher
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

3.  Genome-wide expression monitoring in Saccharomyces cerevisiae.

Authors:  L Wodicka; H Dong; M Mittmann; M H Ho; D J Lockhart
Journal:  Nat Biotechnol       Date:  1997-12       Impact factor: 54.908

4.  The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid.

Authors:  J R Perfect; D L Toffaletti; T H Rude
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  The alpha-mating type locus of Cryptococcus neoformans contains a peptide pheromone gene.

Authors:  T D Moore; J C Edman
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA.

Authors:  D L Toffaletti; T H Rude; S A Johnston; D T Durack; J R Perfect
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

7.  Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans.

Authors:  J K Lodge; E Jackson-Machelski; D L Toffaletti; J R Perfect; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

8.  Cloning the Cryptococcus neoformans TRP1 gene by complementation in Saccharomyces cerevisiae.

Authors:  J R Perfect; T H Rude; L M Penning; S A Johnson
Journal:  Gene       Date:  1992-12-01       Impact factor: 3.688

9.  Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis.

Authors:  F De Bernardis; A Cassone; J Sturtevant; R Calderone
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.

Authors:  Y C Chang; K J Kwon-Chung
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

View more
  23 in total

1.  Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans.

Authors:  Y C Chang; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

Review 2.  Molecular genetic and genomic approaches to the study of medically important fungi.

Authors:  P T Magee; Cheryl Gale; Judith Berman; Dana Davis
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 3.  Strategies for the identification of virulence determinants in human pathogenic fungi.

Authors:  R Alonso-Monge; F Navarro-García; E Román; B Eisman; C Nombela; J Pla
Journal:  Curr Genet       Date:  2003-02-08       Impact factor: 3.886

4.  Mating pheromone in Cryptococcus neoformans is regulated by a transcriptional/degradative "futile" cycle.

Authors:  Yoon-Dong Park; John Panepinto; Soowan Shin; Peter Larsen; Steven Giles; Peter R Williamson
Journal:  J Biol Chem       Date:  2010-08-27       Impact factor: 5.157

5.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Impact of mating type, serotype, and ploidy on the virulence of Cryptococcus neoformans.

Authors:  Xiaorong Lin; Kirsten Nielsen; Sweta Patel; Joseph Heitman
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

7.  Literature-based gene curation and proposed genetic nomenclature for cryptococcus.

Authors:  Diane O Inglis; Marek S Skrzypek; Edward Liaw; Venkatesh Moktali; Gavin Sherlock; Jason E Stajich
Journal:  Eukaryot Cell       Date:  2014-05-09

8.  Three galactose inducible promoters for use in C. neoformans var. grubii.

Authors:  Jack A Ruff; Jennifer K Lodge; Lorina G Baker
Journal:  Fungal Genet Biol       Date:  2008-10-14       Impact factor: 3.495

9.  Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans.

Authors:  Thomas H Rude; Dena L Toffaletti; Gary M Cox; John R Perfect
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response.

Authors:  Yiorgos Apidianakis; Laurence G Rahme; Joseph Heitman; Frederick M Ausubel; Stephen B Calderwood; Eleftherios Mylonakis
Journal:  Eukaryot Cell       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.